ArticleGut2013
Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10.
Article in Gut, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed.
- Fibrolamellar hepatocellular carcinoma: Advances, challenges and opportunities in a rare malignancy.World journal of gastrointestinal surgery · 2025Review
- Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver.Journal of hepatocellular carcinoma · 2023Review
- Development and validation of a nomogram for predicting the cancer-specific survival of fibrolamellar hepatocellular carcinoma patients.Updates in surgery · 2022Article
- Human liver organoids for disease modeling of fibrolamellar carcinoma.Stem cell reports · 2022Article
- Chemical, Molecular, and Single-nucleus Analysis Reveal Chondroitin Sulfate Proteoglycan Aberrancy in Fibrolamellar Carcinoma.Cancer research communications · 2022Article
- Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event.World journal of gastrointestinal oncology · 2022Review
- Multiomic analysis of microRNA-mediated regulation reveals a proliferative axis involving miR-10b in fibrolamellar carcinoma.JCI insight · 2022Article
- Factors Influencing Overall Survival for Patients with Fibrolamellar Hepatocellular Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results Database.International journal of general medicine · 2022Article
- Liver transplantation in malignant disease.World journal of clinical oncology · 2021Review
- Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports.Journal of medical case reports · 2021Article
- Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps.Clinical and molecular hepatology · 2020Article
- Spontaneous Rupture of Fibrolamellar Variant Hepatocellular Carcinoma.Gastroenterology research · 2019Article
- Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma.Journal of gastrointestinal oncology · 2019Article
- Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα.Structure (London, England : 1993) · 2019Article
- The fusion landscape of hepatocellular carcinoma.Molecular oncology · 2019Article
- Imaging findings of hepatic epithelioid hemangioendothelioma and fibrolamellar hepatocellular carcinoma: a critical appraisal of current literature about imaging features of two rare liver cancers.Translational cancer research · 2019Review
- Progression after Immunotherapy for Fibrolamellar Carcinoma.Visceral medicine · 2019Article
- High PKM2 expression is independently correlated with decreased overall survival in hepatocellular carcinoma.Oncology letters · 2018Article
- Precision oncology in liver cancer.Annals of translational medicine · 2018Review
- Intracranial metastasis in fibrolamellar hepatocellular carcinoma.Pediatric blood & cancer · 2018Article
Corrections and comments
- Comment on
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.